GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance
W. L. Gore & Associates, Inc. (Gore) is celebrating the 20th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft for the treatment of complex peripheral vascular disease. The device has been engineered to effectively cover and seal off diseased tissue, providing an endoluminal bypass option for physicians faced with complex, challenging lesions. Since the first implant in Europe in 1996, the device formerly known as the GORE® HEMOBAHN® Endoprosthesis has continuously evolved, now offering CBAS Heparin Surface, lengths up to 25 cm, radiopaque markers, a low profile design, and multiple indications for use. The GORE VIABAHN Endoprosthesis is backed by an ever-growing body of clinical data, including nine randomized or prospective multicenter studies. This continued device evolution and extensive body of clinical proof have enabled the GORE VIABAHN Endoprosthesis to become many physicians’ go-to device for their most challenging cases, selling more than 700,000 units worldwide since its launch.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160907005060/en/
GORE® VIABAHN® Endoprosthesis (Photo: Business Wire)
“The original introduction of the GORE VIABAHN Endoprosthesis as the first SFA stent-graft with proven patency demonstrated the potential of endoluminal bypass. Since then, the expanded clinical indications for use and product improvements have helped me to achieve positive results in patients with complex disease where often, no other therapy is appropriate and able to achieve good clinical long-term results,” said Prof. Johannes Lammer, MD, former Director of Cardiovascular and Interventional Radiology, AKH - Wien, Medical University Vienna, Vienna, Austria, one of the earliest users of the device.
The GORE VIABAHN Endoprosthesis is the only stent or stent-graft to receive U.S. Food and Drug Administration approval for use in the superficial femoral artery (SFA) (including de novo or restenotic lesions and in-stent restenosis of bare metal stents), iliac artery, and arteriovenous (AV) access. The GORE VIABAHN Endoprosthesis portfolio spans a wide variety of sizes, including the recently added 7.5 cm and 25 cm length versions, the industry’s longest such device. The dynamic range of options allows physicians to effectively cover complex lesions in the most challenging clinical situations.
“In the ever-evolving field of interventional medicine, we can’t rely as much on rule-of-thumb and past experiences. Clinical practice is continually refined as new device and procedure options are introduced to the market. We need rigorous clinical trials to gauge the efficacy of devices in a real-world patient population. Throughout the years, Gore has continued to evaluate the GORE VIABAHN Endoprosthesis in challenging, real-world cases, such as long lesions, AV access outflow stenosis, and in-stent restenosis in the SFA, progressing our treatment options in these very complex cases,” said Richard R. Saxon, MD, FSIR, Director of Research, SDCVI, San Diego Imaging Medical Group, San Diego, CA.
Later this month, in conjunction with the Vascular Interventional Advances 2016 (VIVA) Conference in Las Vegas, Gore will release new data from the most recent clinical study on the device’s performance in treating long, complex lesions in the SFA. Prof. Takao Ohki, MD, PhD, of the Jikei University School of Medicine in Tokyo, Japan, will be presenting 12-month results from the GORE VIABAHN Endoprosthesis Japanese Investigational Device Exemption (IDE) Clinical Study on Tuesday, September 20, at a sponsored breakfast symposium. More information about the GORE VIABAHN Endoprosthesis and the study results to be presented at VIVA 2016 can be found here: https://www.goremedical.com/viabahn-patency.
“During the last two decades, we have seen stent-grafts progress to become a primary treatment option for complex peripheral vascular disease. From the introduction of the endoluminal bypass to the market in 1996, Gore has worked in partnership with the endovascular community to innovate, developing smaller profiles, a thromboresistant surface, and new lengths and diameters, all of which help improve patient outcomes,” said Ray Swinney, Peripheral Interventional Business Unit Leader at Gore.
The GORE VIABAHN Endoprosthesis is constructed with a biocompatible, durable, reinforced, expanded polytetrafluoroethylene (ePTFE) liner. Its flexible design enables the device to traverse tortuous anatomies and provide durable outcomes in complex disease. The device is also available with CBAS Heparin Surface, the proven, lasting heparin bonding technology designed to resist thrombus formation.
Products listed may not be available in all markets. GORE®, HEMOBAHN®, and VIABAHN® are trademarks of W. L. Gore & Associates. CBAS is a trademark of Carmeda AB, a wholly owned subsidiary of W. L. Gore & Associates, Inc.
ABOUT W. L. GORE & ASSOCIATES
At Gore, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984.
Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1 (858) 457-2436
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
LTI USD Revenue Growth up 23.4% YoY; Net Profit Jumps 35.2% YoY23.7.2018 14:53 | Pressemelding
Larsen & Toubro Infotech (BSE: 540005, NSE: LTI), a global technology consulting and digital solutions company, announced its Q1 FY19 results today. In US Dollars: Revenue at USD 319.9 million; growth of 3.5% QoQ and 23.4% YoY Constant Currency Revenue growth of 5.1% QoQ and 22.9% YoY In Indian Rupees: Revenue at Rs 21,557 million; growth of 7.7% QoQ and 29.0% YoY Net Income at Rs 3,612 million; growth of 24.8% QoQ and 35.2% YoY “We are pleased to report a strong start to the year with 5.1% QoQ revenue growth in constant currency. Our growth has been driven by continued healthy momentum across multiple sectors, with double-digit sequential growth in BFS and High-Tech & Media in Q1. We are also happy to announce a large deal with a Global Fortune 100 consumer and pharmaceutical giant with a net-new TCV win in excess of US$ 50 Mn. “Our focus on leveraging digital technologies to solve the challenges of physical and digital convergence is resonating with our clients and has laid the found
TRIGO Deepens its Expansion into the USA by Acquiring Lumbee Enterprises23.7.2018 13:00 | Pressemelding
TRIGO has acquired 100% of the capital of Lumbee Enterprises based in Greer, SC. This acquisition allows TRIGO to deepen its expansion into the USA within the automotive industry. Lumbee began providing supply chain and logistics services over 25 years ago and it’s TRIGO’s intent to leverage Lumbee’s proven expertise to further expand its business. Lumbee is best known for its expertise in Quality Manufacturing, Sorting, Inspection and Sub-Assembly Operations, specializing in providing best-in-class inspection and rework services to keep OEM assembly lines running seamlessly and without interruption. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180723005040/en/ Co-founded by Colby Griffin in 2001, LUMBEE Enterprises of South Carolina has focused on providing quality management services to shorten supply chain interruptions through the innovative use of technology and processes. “This acquisition is a great opportunity for
STATS Taps Dr. Helen Sun, Former CTO of JPMorgan Chase Commercial Banking Division, to Lead STATS’ Technology Operations23.7.2018 11:00 | Pressemelding
Today, STATS, the worldwide leader in sports data and intelligence, expanded its executive roster with the introduction of Dr. Helen Sun as Chief Technology Officer. Sun will oversee STATS’ product, engineering, artificial intelligence and data production teams in developing the next generation of products and services that will revolutionize the performance and experience of sports. Sun joins STATS from JPMorgan Chase, most recently serving as Chief Technology Officer of the Commercial Banking division. For over 22 years, Sun has a proven record as a technology strategist and thought leader in previous roles as Vice President of Cloud Computing, Information Management, and Architecture at Motorola Solutions; Senior Director of Global Enterprise Architecture at Salesforce; and Director of Enterprise Architecture at Oracle. “Helen is a leader in transforming businesses through innovative solutions and she will be a driving force in building upon our reputation as the leading sports tech
IBC2018 Enhances Conference Programme with Keynote Sessions from Amazon, Viacom and Wonderhood Studios23.7.2018 10:57 | Pressemelding
IBC2018, the world’s most influential media, entertainment and technology show, today announces three new Keynote speakers from globally renowned media and entertainment powerhouses. The addition of executives from Amazon, Viacom and Wonderhood Studios adds to the big-name line up of thought provoking and informative sessions and speakers already announced by IBC. Taking to the stage on the first day of the conference, Thursday 13 September, to deliver the Trailblazer Keynote session entitled ‘Give Your Vision a Voice’ is Max Amordeluso, EU Lead Evangelist Amazon Alexa, Amazon. As voice assistants such as Amazon Alexa are transforming the way audiences discover content and control devices, Amordeluso’s must-attend presentation will explore a variety of avenues, including: how to build a voice strategy with Alexa; why voice experiences are now a crucial part of any multi-platform content business; how to implement an engaging voice strategy for content products and generate new revenues
SIGOS: Digital Experience - 120 mobile network operators from 60 countries meet in Nuremberg23.7.2018 10:06 | Pressemelding
For more than 10 years, SIGOS has been inviting mobile network operators from all over the world to the annual telecommunications conference. After venues such as Düsseldorf, Berlin, Munich, Beijing, Kuala Lumpur, etc., this year's multi-day conference took place at the Nuremberg convention centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180723005282/en/ SIGOS conference panel discussion - photo: www.uwe-niklas.com Over 120 network operators and telecommunications companies from over 60 countries worldwide came together to talk about the latest innovations in areas such as network quality, performance, 5G, IoT, roaming, and telecommunications fraud detection solutions. Dr. Ulrich Maly, Lord Mayor of the City of Nuremberg, welcomed the international audience in his opening speech and explained:"...when we talk about mobile communication, then we talk about people and their needs that are and should be the focus of atte
AURAK Enters into a Memorandum of Understanding with Al-Farabi Kazakh National University22.7.2018 09:52 | Pressemelding
The American University of Ras Al Khaimah (AURAK) President, Professor Hassan Hamdan Al Alkim, and the Al-Farabi Kazakh National University (KazNU) Rector, Professor Galimkair Mutanov, of the Republic of Kazakhstan, signed a Memorandum of Understanding (MoU), agreeing to exchange students, faculty, and research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180722005025/en/ The Al-Farabi Kazakh National University (KazNU) Rector, Professor Galimkair Mutanov, of the Republic of Kazakhstan and the American University of Ras Al Khaimah (AURAK) President, Professor Hassan Hamdan Al Alkim, exchange a gift to commemorate their universities uniting in an MoU agreement. (Photo: AETOSWire) In the spirit of fostering a close international relationship between the Republic of Kazakhstan and the United Arab Emirates, developing bilateral relations in educational and scientific fields, and wishing to make their own contributions to the